¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"exposure calibration factor"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
public exposure
°ø°øÇÇÆø, °ø°ø³ëÃâ
permissible exposure limit
Çã¿ë³ëÃâÇѰè, Çã¿ëÇÇÆøÇѰè
permissible radiation exposure level
Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
radiation exposure
¹æ»ç¼±³ëÃâ
subanesthetic exposure
Áظ¶Ãë³ëÃâ
sun exposure
ÇÞºû³ëÃâ, Àϱ¤³ëÃâ
short term exposure
´Ü±â³ëÃâ
antihemophilic factor
Ç×Ç÷¿ìº´ÀÎÀÚ
antineuritic factor
Ç׽Ű濰ÀÎÀÚ
antipellagra factor
Çׯç¶ó±×¶óÀÎÀÚ
antiphagocytic factor
Çׯ÷½ÄÀÎÀÚ, Ç׎½ÄÀÎÀÚ
antiplatelet factor
Ç×Ç÷¼ÒÆÇÀÎÀÚ
antirachitic factor
Ç×±¸·çº´ÀÎÀÚ
antiscorbutic factor
Ç×±«Ç÷º´ÀÎÀÚ
antisterility factor
Ç׺ÒÀÓÀÎÀÚ
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
11
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
platelet-derived growth factor
Ç÷¼ÒÆÇÀ¯·¡¼ºÀåÀÎÀÚ, Ç÷¼ÒÆÇ±â¿ø¼ºÀåÀÎÀÚ
precipitation factor
ÃËÁø¿äÀÎ
predisposing factor
¼±Çà¿äÀÎ
prognostic factor
¿¹ÈÄÀÎÀÚ
psychological factor
½É¸®¿ä¼Ò
relaxing factor
ÀÌ¿ÏÀÎÀÚ
resistance factor
³»¼ºÀÎÀÚ, °ßµõÀÎÀÚ
rheumatoid factor
·ù¸¶Æ¼½ºÀÎÀÚ
risk factor
À§ÇèÀÎÀÚ
transforming growth factor
Àüȯ¼ºÀåÀÎÀÚ
vascular endothelial growth factor
Ç÷°ü³»ÇǼºÀåÀÎÀÚ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
exposure ratio
³ëÃâºñÀ²
exposure time
³ëÃâ½Ã°£, Æø·Î½Ã°£
exposure-odds ratio
³ëÃâ±³Â÷ºñ
occupational exposure
Á÷¾÷³ëÃâ
prolonged exposure
Àå±â³ëÃâ
public exposure
°øÁßÇÇÆø, °øÁß³ëÃâ
radiation exposure
¹æ»ç¼±³ëÃâ
short term exposure
´Ü±â³ëÃâ
subanesthetic exposure
Áظ¶Ãë³ëÃâ
sun exposure
Àϱ¤³ëÃâ
permissible exposure limit
Çã¿ëÇÇÆøÇѰè
permissible radiation exposure level
Çã¿ë¹æ»ç¼±ÇÇÆø¼±·®
absorbed dose conversion factor
Èí¼ö¼±·®º¯È¯°è¼ö
activation factor
Ȱ¼ºÀÎÀÚ
alveolar dilution factor
ÆóÆ÷Èñ¼®ÀÎÀÚ, ÇãÆÄ²Ê¸®Èñ¼®ÀÎÀÚ
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
Christmas factor
Å©¸®½º¸¶½º ÀÎÀÚ(ì×í)
Christmas factor.
Å©¸®½º¸¶½ºÀÎÀÚ
D factor
DÀÎÀÚ
Decay accelerating factor
ºØ±«°¡¼Ó¿ä¼Ò(¿äÀÎ)
EDCF (endothlium-derived contracting factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ¼öÃàÀÎÀÚ(â¥õêì×í)
EDRF (endothlium-derived relaxing factor)
³»ÇǼ¼Æ÷¼º(Ò®ù«á¬øààõ) ÀÌ¿ÏÀÎÀÚ(ì¬èÐì×í)
EDRF=£¾endothelium derived relaxing factor
³»ÇǼ¼Æ÷¼ºÀÌ¿ÏÀÎÀÚ.
F factor
FÀÎÀÚ
Factor IX
IX ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor V
V ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor VII
VII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor VIII
VIII ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor X activated
Ȱ¼ºÈ(üÀàõûù)µÈ X ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor XI
XI ÀÀ°íÀÎÀÚ(ëêͳì×í)
Factor XII
XII ÀÀ°íÀÎÀÚ(ëêͳì×í)
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
output calibration
Ãâ·ÂÃøÁ¤
pressure calibration
À½¾Ð±³Á¤
accidental exposure
»ç°í½ÃÇÇÆø, °ú½ÇÇÇÆø
acute exposure
±Þ¼ºÇÇÆø
chemical exposure
ÈÇÐÀû ³ëÃâ<Æø·Î
chronic exposure
¸¸¼ºÇÇÆø
continuous exposure
¿¬¼ÓÇÇÆø
double exposure technique
Áߺ¹ X¼±ÃÔ¿µ¼ú
exposure
ÇÇÆø
exposure dose
Á¶»ç·®.
exposure keratitis
³ëÃâ°¢¸·¿°(ÖÚõóÊÇØ¯æú).
exposure keratopathy
³ëÃâ°¢¸·º´Áõ
exposure meter
³ëÃâ°è(ËȨ̀Ë).
exposure of person
½Åü ³ëÃâ.
exposure rate
ÇÇÆøÀ²
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½